前收市價 | 64.80 |
開市 | 65.11 |
買盤 | 65.25 x 100 |
賣出價 | 65.42 x 100 |
今日波幅 | 64.50 - 66.07 |
52 週波幅 | 25.98 - 110.25 |
成交量 | |
平均成交量 | 2,051,490 |
市值 | 6.827B |
Beta 值 (5 年,每月) | 0.68 |
市盈率 (最近 12 個月) | 無 |
每股盈利 (最近 12 個月) | -5.45 |
業績公佈日 | 2024年5月08日 |
遠期股息及收益率 | 無 (無) |
除息日 | 無 |
1 年預測目標價 | 95.06 |
These two biotech stocks could be big winners in the years ahead.
Why do you want to consider biotech stocks? Simply, the narrative comes down to numbers and a possible rotation. First, the hard data supports bullishness in biotech stocks. According to Grand View Research, the underlying global industry reached a valuation of $1.55 trillion last year. Moving forward, experts project that the sector will expand at a compound annual growth rate (CAGR) of 13.96% from 2024 to 2030. At the culmination point, the space may be worth $3.88 trillion. Second, a sector r
In this article, we will be taking a look at the 30 biggest biotechnology companies in the world. If you do not want to learn about the global biotech market, head straight to the 5 Biggest Biotechnology Companies in the World. In the ever-evolving landscape of biotechnology, several companies like Novo Nordisk, Regeneron, and United […]